Duke researchers link brain tumor drug resistance to mismatch repair deficiency.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics; D004249:DNA Damage; D004260:DNA Repair; D004273:DNA, Neoplasm; D019008:Drug Resistance, Neoplasm; D005909:Glioblastoma / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D051379:Mice; D011344:Procarbazine / Q000494:pharmacology*
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D011344:Procarbazine